印度

HETERO DRUGS LTD (UNIT I)

会员限时活动

1580 元/年

交易概况

总交易额

186,316.00

交易次数

20

平均单价

9,315.80

最近交易

2024/12/16

HETERO DRUGS LTD (UNIT I) 贸易洞察 (供应商)

过去5年，HETERO DRUGS LTD (UNIT I)在印度市场展现出 保持稳定的贸易往来。 总交易额达 186,316.00 ，累计 20 笔交易。 平均单价 9,315.80 ，最近一次交易于 2024/12/16。

贸易记录

日期 交易公司 交易描述 数量 金额
2023-05-22 SAVI PHARMACEUTICAL JOINT STOCK COMPANY Other Pharmaceutical Ingredients: Topiramate (Topiramat), USP 43 , SDK: VD-27054-17, Patient: TA23040026, NSX: 04/2023 HD:04/2025, NSX: Hetero Drugs Limited (Unit-I)- India . 25.00Kilograms 4375.00USD
2024-07-15 CUU LONG PHARMACEUTICAL JOINT STOCK COMPANY Pharmaceutical raw materials used to research PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDARTE; Standard USP42-45; Lot:PH24040004 (4/21/24- 4/20/29) , Manufacturer: Hetero Drugs Limited (Unit-I) 10.00Gram 10.00USD
2024-12-16 PYMEPHARCO Pharmaceutical ingredients: Glimepiride - TC: Current USP + NSX - Lot: GP24110023 - Date: 11/2024 - 11/2029- NSX: Hetero Drugs Limited (Unit-I). VD-24959-16 20.00Kilograms 22000.00USD
2024-09-04 PYMEPHARCO Pharmaceutical substance for research and testing: Lercanidipine Hydrochloride Hemihydrate - TC: NSX - Lot: LE23050038 - Date: 05/2023 - 05/2028 - Manufacturer: Hetero Drugs Private Limited (Unit - I) - India 25.00Kilograms 21250.00USD
2024-07-15 ASIA CHEMICAL CORPORATION GLIMEPIRIDE Pharmaceutical Raw Materials - Manufacturer: January 2024 - NHH: January 2029, Manufacturer: HETERO DRUGS LIMITED (UNIT I), Pharmaceutical substance standard: USP NF2023, Lot: GP24010008, 20 kg/drum, 100% new product 20.00Kilograms 22000.00USD
2024-02-19 PHARBACO CENTRAL PHARMACEUTICAL JOINT STOCK COMPANY NO1 Citalopram hydrobromide USP43; NL produces SSRI selective reuptake inhibitors; 100% new; batchno: CT23080009; Production date: July 29, 2023; Expiry date: July 28, 2028; Manufacturer: Hetero Drugs Limited. 40.00Kilograms 7400.00USD

贸易国家分析

HS编码情报

HS编码 产品描述 频次
854140 光电二极管、晶体管、类似半导体器件 42
847130 便携式数字处理设备 35
851762 无线网络接入设备 28
847330 电子计算机零件 22
852910 天线和天线反射器 18
853400 印刷电路板 15